Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Admission

31 Jul 2006 08:56

Imperial Innovations Group plc31 July 2006 For Immediate Release 31 July 2006 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO ORFROM THE UNITED STATES, CANADA, AUSTRALIA, REPUBLIC OF IRELAND OR JAPAN OR ANYOTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANTLAWS OF SUCH JURISDICTION. This announcement does not constitute an offer orinvitation to purchase or subscribe for any securities. Imperial Innovations Group plc Admission and start of unconditional dealings on AIM Imperial Innovations Group plc (the "Company"), which is the holding company ofImperial Innovations Limited, one of the leading technology commercialisationcompanies in the UK, today announces the admission of its ordinary shares of 3 1/33 pence each ("Ordinary Shares") to the AIM Market of London Stock Exchangeplc ("AIM") and the commencement of unconditional dealings ("Admission"). The Company has raised gross proceeds of £25 million through the issue of6,849,315 Ordinary Shares to institutional and certain other investors at aprice of 365 pence (the "Offer Price") per Ordinary Share (the "Placing"). Anadditional 269,285 Ordinary Shares have been issued by the Company to the publicat the Offer Price (the "Public Offer") to raise additional gross proceeds of£982,890. At Admission, the Company has 49,522,205 Ordinary Shares in issue giving theCompany a market capitalisation, based on the Offer Price, of approximately£180.8 million. The Ordinary Shares will trade on AIM under the ticker, "IVO". JPMorgan Cazenove Limited ("JPMorgan Cazenove") is nominated advisor and brokerto the Company. Enquiries: Imperial Innovations Group plcMartin Knight (Chairman) +44 (0)20 7594 1403Susan Searle (Chief Executive Officer) +44 (0)20 7594 6644 M:Communications +44 (0)20 7153 1547Patrick d'Ancona JPMorgan Cazenove +44 (0)20 7588 2828Michael Wentworth-Stanley Imperial College London (Press Office) +44 (0)20 7594 6701Abigail Smith The contents of this announcement, which have been prepared by and are the soleresponsibility of the Company, have been approved solely for the purposes ofsection 21(2)(b) of the Financial Services and Markets Act 2000 by JPMorganCazenove of 20 Moorgate, London EC2R 6DA. JPMorgan Cazenove, which is authorised and regulated in the United Kingdom bythe Financial Services Authority, is acting exclusively for the Company and noone else in connection with the Placing, the Public Offer and Admission and willnot be responsible to anyone other than the Company for providing theprotections afforded to clients of JPMorgan Cazenove or for providing advice inrelation to the Placing, the Public Offer and Admission or any other mattersreferred to in this announcement. This announcement may not be distributed, directly or indirectly, in or into orfrom the United States, Canada, Australia, Republic of Ireland or Japan. Thisannouncement does not constitute or form part of an offer to sell or issue, orany solicitation of an offer to buy or subscribe for, any securities referred toherein in the United States or in any other jurisdiction. The Placing and thePublic Offer and the distribution of this announcement and other information inconnection with the Placing and the Public Offer in certain jurisdictions may berestricted by law and persons into whose possession any document or otherinformation referred to herein comes should inform themselves about and observeany such restriction. Any failure to comply with these restrictions mayconstitute a violation of the securities laws of any such jurisdiction. The securities mentioned herein have not been, and will not be, registered underthe U.S. Securities Act of 1933 (the "Securities Act"), and may not be offeredor sold in the United States (as such term is defined in Regulation S under theSecurities Act) unless they are registered under the Securities Act or pursuantto an exemption from registration. The price and value of securities may go down as well as up. Persons needingadvice should contact a professional adviser. Information in this announcement or any of the documents relating to the Placingand the Public Offer cannot be relied upon as a guide to future performance. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Nov 20177:00 amRNSExercise of share options
27th Nov 20177:00 amRNSIssue of Equity
13th Nov 20177:01 amRNSBoard changes following cancellation of admission
13th Nov 20177:00 amRNSNotice of cancellation of admission to AIM
27th Oct 201710:54 amRNSPosting of Annual Report
26th Oct 20173:50 pmRNSIssue of Equity
18th Oct 201710:30 amRNSOffer Update; Appointment of Prof. David Begg
18th Oct 20179:38 amRNSUpdated recommendation by Touchstone Innovations
18th Oct 20177:00 amRNSOffer Update - Wholly Unconditional
17th Oct 20179:10 amRNSGrant of share options
17th Oct 20177:36 amRNSOffer Update - CMA clearance and Offer timetable
16th Oct 201710:54 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20179:58 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20177:00 amRNSOffer Update
5th Oct 20178:30 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
4th Oct 20177:00 amRNSTouchstone invests £1.4m in Featurespace round
2nd Oct 201710:32 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
29th Sep 20178:29 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
25th Sep 20179:15 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
21st Sep 20178:56 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
18th Sep 20177:00 amRNSOffer Update
13th Sep 20179:33 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
13th Sep 20177:00 amRNSFinal Results
12th Sep 20171:48 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 20171:46 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 201711:50 amRNSForm 8.3 - Touchstone Innovations Plc
12th Sep 201710:52 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
12th Sep 20177:00 amRNSTouchstone commits funds to Ieso Digital Health
11th Sep 20179:41 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
8th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
8th Sep 20178:51 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
7th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
7th Sep 20178:57 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
30th Aug 20176:21 pmRNSUpdate on Offer for Touchstone Innovations plc
25th Aug 201710:14 amRNSUpdate on Offer for Touchstone and Capital Raising
25th Aug 20179:56 amRNSStatement re: Offer timetable extended
21st Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
17th Aug 20177:00 amRNSFurther re Capital Raising
16th Aug 20173:12 pmRNSForm 8.3 - IP Group Plc
15th Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
1st Aug 20177:00 amRNSPublication of Response Circular
28th Jul 20172:21 pmRNSForm 8.3 - IP Group Plc
27th Jul 20172:52 pmRNSForm 8.3 - IP Group Plc
26th Jul 20172:20 pmRNSForm 8.3 - IP Group Plc
25th Jul 20175:38 pmRNSStatement re clarification of offer for Touchstone
25th Jul 201712:16 pmRNSForm 8.3 - Touchstone Innovations Plc
21st Jul 201712:43 pmRNSForm 8.3 - Touchstone Innovations Plc
20th Jul 201711:35 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:42 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:14 amRNSForm 8.3 - Touchstone Innovations Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.